Terms: = Breast cancer AND PREX2, 6230420N16Rik, DEPDC2, 80243, ENSG00000046889, FLJ12987, DEP_2, P-REX2 AND Prognosis
2 results:
1. Identification of new subtypes and potential genetic signatures in triple-negative breast cancer using weighted gene co-expression network analysis.
Huang J; Liao LY; Jiang WJ; Li YH; Lu BM; Wen ZP; Li FJ; Fang DL; Lu GM
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):603-614. PubMed ID: 38305604
[TBL] [Abstract] [Full Text] [Related]
2. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the prex2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract] [Full Text] [Related]
